Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Biokin (Group)

Founded in 1996, Biokin, after 26 years of steady growth, has become a biopharmaceutical company integrating the full life cycle of new drug and pharmaceutical product development from new drug research and development to production and marketing. Biokin has built a proprietary and fully integrated biological drug development platform in China and the United States, a world-leading tumor antibody drug development platform and research pipeline and owns a comprehensive and well-preserved intellectual property portfolio. Biokin operates a nationally certified technological center and is an inaugural member of the Chinese Pediatric Medicine R&D and Industrialization Alliance. Biokin has won numerous awards, including recognition as "China's Best Industrial Company in Pharmaceutical R&D Product Line." Biokin is a biopharmaceutical company, integrating drug research and development, production, and marketing. Biokin owns R&D centers in China and the United States (US: Systimmune, Inc.; China: Baili Pharmaceutical and Baili-Bio Pharmaceutical, etc.), a biological drug and antibody conjugated drug production facility (Baili-Bio Pharmaceutical), two pharmaceutical formulation facilities (Baili Pharmaceutical and Guorui Pharmaceutical), one active pharmaceutical ingredient production facility (Jingxi Pharmaceutical), one chemical intermediate manufacturer (Hayate Technology) and two pharmaceutical marketing companies (Biokin and Lhasa Xinbo). *

 

Period Start 1996-01-01 established
Products Industry DRUGS, GENERICS
  Industry 2 biopharmaceutical
     
  City n. a. 
    Address record changed: 2017-05-20
     
Basic data Employees n. a.
     
    * Document for »About Section«: SystImmune, Inc.. (1/5/23). "Press Release: Biokin Pharmaceutical Launches Shanghai Initial Public Offering". Chengdu.
     
   
Record changed: 2024-01-13

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Biokin (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top